3/18
02:58 pm
qnrx
Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) had its price target lowered by analysts at Maxim Group from $15.00 to $4.00. They now have a "buy" rating on the stock.
Low
Report
Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) had its price target lowered by analysts at Maxim Group from $15.00 to $4.00. They now have a "buy" rating on the stock.
3/15
11:05 am
qnrx
Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/13
04:09 pm
qnrx
Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Results [Yahoo! Finance]
High
Report
Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Results [Yahoo! Finance]
3/13
04:05 pm
qnrx
Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Results
High
Report
Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Results
3/7
04:05 pm
qnrx
Quoin Pharmaceuticals Announces Fourth Quarter and 2023 Financial Results and Corporate Update Conference Call to be held on Thursday March 14th at 8:30 am ET
Medium
Report
Quoin Pharmaceuticals Announces Fourth Quarter and 2023 Financial Results and Corporate Update Conference Call to be held on Thursday March 14th at 8:30 am ET
3/5
08:10 am
qnrx
Quoin Pharmaceuticals Announces Pricing of $6.5 Million Public Offering [Yahoo! Finance]
Medium
Report
Quoin Pharmaceuticals Announces Pricing of $6.5 Million Public Offering [Yahoo! Finance]
3/5
08:00 am
qnrx
Quoin Pharmaceuticals Announces Pricing of $6.5 Million Public Offering
High
Report
Quoin Pharmaceuticals Announces Pricing of $6.5 Million Public Offering
3/4
08:16 am
qnrx
Quoin Pharmaceuticals Announces FDA Clearance to Recruit Teen Subjects into Both Ongoing Netherton Syndrome Clinical Studies [Yahoo! Finance]
High
Report
Quoin Pharmaceuticals Announces FDA Clearance to Recruit Teen Subjects into Both Ongoing Netherton Syndrome Clinical Studies [Yahoo! Finance]
3/4
08:00 am
qnrx
Quoin Pharmaceuticals Announces FDA Clearance to Recruit Teen Subjects into Both Ongoing Netherton Syndrome Clinical Studies
High
Report
Quoin Pharmaceuticals Announces FDA Clearance to Recruit Teen Subjects into Both Ongoing Netherton Syndrome Clinical Studies
2/8
08:18 am
qnrx
Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Netherton Syndrome Combination Product [Yahoo! Finance]
Medium
Report
Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Netherton Syndrome Combination Product [Yahoo! Finance]
2/8
08:00 am
qnrx
Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Netherton Syndrome Combination Product
Medium
Report
Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Netherton Syndrome Combination Product